Cite Filings / IRLA / 0000950170-22-002571
Feed Companies Filings Check
Sign in
10-K

Annual Report

IRulya Therapeutics Inc. · Filed 2022-03-01 · Acc 0000950170-22-002571

Documents 1

  • 10-K Annual Report , crtx-20211231.htm

Around this filing

  • 2023-03-15 10-K Annual Report
  • 2022-03-04 4 Chief Legal & Adm. Officer acquired 140,000 shares (grant or award)
  • 2022-03-04 4 EVP, Preclinical Development acquired 155,500 shares (grant or award)
  • 2022-03-04 4 Chief Medical Officer acquired 140,000 shares (grant or award)
  • 2022-03-01 S-8 Securities Offered to Employees in Benefit Plans
  • 2022-03-01 10-K Annual Report
  • 2021-03-01 10-K Annual Report

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
  • SEC Structured Data (opens in new tab)
Loading crtx-20211231.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…